A Prompt-Based Tutorial for Large Language Model-Assisted Screening in Systematic Reviews and Meta-Analyses [0.03%]
基于提示的大语言模型辅助系统评价和 meta 分析筛选的教程
Tongyu Qiu,Huangqi Jiang,Mark S Chen et al.
Tongyu Qiu et al.
Demonstrating transportability of real-world evidence: what do HTA bodies and health technology developers need? [0.03%]
真实世界证据外推性示范:卫生技术评估机构和卫生技术开发者需要什么?
Ashley A Jaksa,Blythe Adamson,Robert Szulkin et al.
Ashley A Jaksa et al.
Real-world evidence (RWE) is reshaping how health technology assessment (HTA) bodies evaluate therapies, yet a critical gap persists: while transportability methods enable researchers to adapt treatment effect estimates from RWE studies in ...
Reporting the use of AI in Horizon Scanning: A brief communication on methodological standards [0.03%]
人工智能在地平线扫描中的应用报告:关于方法标准的简要交流
Hannah OKeefe,Claire Eastaugh,Chris Marshall
Hannah OKeefe
Detecting Gaps for Innovation in HTA: Analysis of Technological Submissions as a Strategy for Translational Research [0.03%]
创新中的卫生技术评估缺口检测:作为转化研究战略的技术提交分析
Laís Lopes,Bernardo Soares Fernandes,Alessandro Nakoneczny Schildt et al.
Laís Lopes et al.
Systematic Review of Health Economic Evaluations Published in Lebanon: Summary of Current Practice, a Critical Appraisal, and Recommendations for Future Studies [0.03%]
黎巴嫩发表的卫生经济学评价系统性回顾:当前实践总结、批判性评估及对未来研究的建议
Wadih Mina,Rana Rizk,David Burns et al.
Wadih Mina et al.
Jennifer C Goldsack
Jennifer C Goldsack
Developing and Implementing a Protocol for Evaluating Patient Involvement in Health Technology Assessment: The Experience of the Spanish HTA Network (RedETS) [0.03%]
评价卫生技术评估中患者参与的协议制定和实施:西班牙HTA网络(RedETS)的经验
Eva Reviriego-Rodrigo,Paula Cantero-Muñoz,Laura Llinàs-Mallol et al.
Eva Reviriego-Rodrigo et al.
Assessing the conflict-of-interest reporting practices in published health technology assessment reports [0.03%]
评估已发表的卫生技术评估报告中的利益冲突披露实践
Miro Vuković,Filipa Alpeza,Ana Marušić
Miro Vuković
From task validation to workflow assurance in Health Technology Assessment [0.03%]
从卫生技术评估中的任务验证到工作流程保障
Gaurav Agarwal,Sharmila Chaudhuri
Gaurav Agarwal
Consideration of intersectoral costs and benefits in health economic evaluations of pneumococcal conjugate vaccines: a systematic review [0.03%]
肺炎球菌结合疫苗卫生经济学评价中业际成本效益考量的系统综述
Emad Almomani,Musa Dukuray,Inge van der Putten et al.
Emad Almomani et al.
Objectives: This systematic review explores which intersectoral costs and benefits (ICBs) are considered in the economic evaluation of pneumococcal conjugate vaccines (PCVs) across different age groups and the related imp...